Cucurbitacin B causes increased radiation sensitivity of human breast cancer cells via G2/M cell cycle arrest

Journal of Oncology

Volumn , Issue , 2012, Pages

  Duangmano, Suwit ^a,b   Sae Lim, Phorntip ^c   Suksamrarn, Apichart ^c   Patmasiriwat, Pimpicha ^a   Domann, Frederick E ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF IOWA   (United States)

^c RAMKHAMHAENG UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CESIUM 137; CUCURBITACIN; CUCURBITACIN B; MESSENGER RNA; PROTEIN P21; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL CLONE; CELL SURVIVAL; COLONY FORMING CELL; CONTROLLED STUDY; DNA CONTENT; DOSE RESPONSE; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GAMMA RADIATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RADIOSENSITIVITY; RADIOSENSITIZATION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 84862280414     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/601682     Document Type: Article

References (26)

1. Ferlay J., Shin H. R., Bray F., Forman D., Mathers C., Parkin D. M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 International Journal of Cancer 2010 127 12 2893 2917
2. Jemal A., Siegel R., Xu J., Ward E., Cancer statistics, 2010 CA Cancer Journal for Clinicians 2010 60 5 277 300
3. Kols A., Breast cancer: increasing incidence, Limited Options Out Look 2002 19 4 1 8
4. Konecny G., Pauletti G., Pegram M., Untch M., Dandekar S., Aguilar Z., Wilson C., Rong H. M., Bauerfeind I., Felber M., Wang H. J., Beryt M., Seshadri R., Hepp H., Slamon D. J., Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer Journal of the National Cancer Institute 2003 95 2 142 153 (Pubitemid 36193263)
5. Bauer K. R., Brown M., Cress R. D., Parise C. A., Caggiano V., Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry Cancer 2007 109 9 1721 1728 (Pubitemid 46668532)
6. Kim M. J., Ro J. Y., Ahn S. H., Kim H. H., Kim S. B., Gong G., Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes Human Pathology 2006 37 9 1217 1226 (Pubitemid 44286991)
7. Wiwat C., Silapa-archa W., The antimicrobial activities of Cucurbitaceous plants Mahidol University Journal of Pharmaceutical Sciences 1984 11 12 18
8. Jayaprakasam B., Seeram N. P., Nair M. G., Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana Cancer Letters 2003 189 1 11 16 (Pubitemid 35351514)
9. Wakimoto N., Yin D., O'Kelly J., Haritunians T., Karlan B., Said J., Xing H., Koeffler H. P., Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo Cancer Science 2008 99 9 1793 1797
10. Liu T., Peng H., Zhang M., Deng Y., Wu Z., Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin European Journal of Pharmacology 2010 641 1 15 22
11. Iwanski G. B., Lee D. H., En-Gal S., Doan N. B., Castor B., Vogt M., Toh M., Bokemeyer C., Said J. W., Thoennissen N. H., Koeffler H. P., Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer British Journal of Pharmacology 2010 160 4 998 1007
12. Chan K. T., Meng F. Y., Li Q., Ho C. Y., Lam T. S., To Y., Lee W. H., Li M., Chu K. H., Toh M., Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration Cancer Letters 2010 294 1 118 124
13. Lee D. H., Thoennissen N. H., Goff C., Iwanski G. B., Forscher C., Doan N. B., Said J. W., Phillip Koeffler H., Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma Cancer Letters 2011 306 2 161 170
14. Haritunians T., Gueller S., Zhang L., Badr R., Yin D., Xing H., Fung M. C., Koeffler H. P., Cucurbitacin B induces differentiation, cell cycle arrest, and actin cytoskeletal alterations in myeloid leukemia cells Leukemia Research 2008 32 9 1366 1373
15. Duangmano S., Dakeng S., Jiratchariyakul W., Suksamrarn A., Smith D. R., Patmasiriwat P., Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc/hTERT/ telomerase pathway and obstruction of the cell cycle International Journal of Molecular Sciences 2010 11 12 5323 5338
16. Pawlik T. M., Keyomarsi K., Role of cell cycle in mediating sensitivity to radiotherapy International Journal of Radiation Oncology Biology Physics 2004 59 4 928 942 (Pubitemid 38834285)
17. Terasima T., Tolmach L. J., X-ray sensitivity and DNA synthesis in synchronous populations of HeLa cells Science 1963 140 3566 490 492
18. Sinclair W. K., Morton R. A., X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells Radiation Research 1966 29 3 450 474
19. Geng C. X., Zheng Z. C., Wang J. Y., Xuan S. Y., Lin C. M., Docetaxel shows radiosensitization in human hepatocellular carcinoma cells World Journal of Gastroenterology 2005 11 19 2990 2993
20. Chen J. C., Chiu M. H., Nie R. L., Cordel G. A., Qiuz S. X., Cucurbitacins and cucurbitane glycosides: structures and biological activities Natural Product Reports 2005 22 3 386 399 (Pubitemid 40885718)
21. Farias M. R., Schenkel E. P., Mayer R., Rucker G., Cucurbitacins as constituents of Wilbrandia ebracteata Planta Medica 1993 59 3 272 275 (Pubitemid 23168780)
22. Kongtun S., Jiratchariyakul W., Kummalue T., Tan-ariya P., Kunnachak S., Frahm A. W., Cytotoxic properties of root extract and fruit juice of Trichosanthes cucumerina Planta Medica 2009 75 8 839 842
23. Dakeng S., Duangmano S., Jiratchariyakul W., U-Pratya Y., Bgler O., Patmasiriwat P., Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt associated proteins and reduced translocation of galectin-3-mediated -catenin to the nucleus Journal of Cellular Biochemistry 2012 113 1 49 60
24. Pradier O., Rave-Frnk M., Schmidberger H., Bmecke M., Lehmann J., Meden H., Hess C. F., Effects of paclitaxel in combination with radiation on human head and neck cancer cells (ZMK-1), cervical squamous cell carcinoma (CaSki), and breast adenocarcinoma cells (MCF-7) Journal of Cancer Research and Clinical Oncology 1999 125 1 20 27 (Pubitemid 29062332)
25. Leonard C. E., Chan D. C., Chou T. C., Kumar R., Bunn P. A., Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck Cancer Research 1996 56 22 5198 5204 (Pubitemid 26383036)
26. Sheikh M. S., Chen Y. Q., Smith M. L., Fornace A. J., Role of p21(Waf1/Cip1/Sdi1) in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells Oncogene 1997 14 15 1875 1882 (Pubitemid 27207689)